Ikarian Capital, LLC
- SEC CIK
- 0001778253
- Latest filing
- Aug 14, 2026
ROIV holding history
Roivant Sciences Ltd. in every 13F filed by Ikarian Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ROIV overviewAll 13F holders of ROIVFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −100,609−100.0% | Sold out | Holders |
| Q3 2024 | 100,609 | $1.16M | 0.4% | 00.0% | Unchanged | Holders |
| Q2 2024 | 100,609 | $1.06M | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2024 | 100,609 | $1.06M | 0.3% | −51,212−33.7% | Reduced | Holders |
| Q4 2023 | 151,821 | $1.70M | 0.5% | +150,000+8,237.2% | Added | Holders |
| Q3 2023 | 1,821 | $21.3K | <0.1% | −223,179−99.2% | Reduced | Holders |
| Q2 2023 | 225,000 | $2.27M | 0.8% | −350,000−60.9% | Reduced | Holders |
| Q1 2023 | 575,000 | $4.24M | 1.8% | +575,000 | New | Holders |